COVID-19 and HIV
CHIVA have set this page up to provide professionals with updated information in relation to COVID -19, as new information and evidence becomes available we will share it here.
5th May 2020
Paediatric multisystem inflammatory syndrome temporally associated with COVID-19
Although most children are asymptomatic or exhibit mild symptoms from COVID-19 infection, a small number have recently been identified who develop a significant systemic inflammatory response. The RCPCH have produced guidance for clinicians, developed after expert review of the cases. This includes a case definition and approach to clinical management.
24th March 2020 CHIVA statement on COVID-19 and HIV following release of Public Health England (PHE) guidance on shielding and protecting extremely vulnerable people
There is no current evidence that people living with HIV who have a good CD4 count and an undetectable viral load, are at increased risk from COVID-19 compared to the general population.
The following recommendations for children, young people and families are based on current available evidence and expert opinion and are in accordance with advice for adults from BHIVA:
- Children and young people living with HIV who have an undetectable viral load and normal CD4 count and do not have any other long-term health problems should follow advice below for the general population on social distancing.
The following people should follow social distancing advice stringently:
- Children and young people with a CD4 count of less than 200, a detectable viral load, or those not on ART.
- Children and young people with other long-term conditions identified in the PHE guidance and also any with severe bronchiectasis. (condition affecting the lung airways)
- Pregnant women living with HIV
- Children and young people living with HIV who have a CD4 count less than 50, who have had an opportunistic illness within the last 6 months, or who have one of the conditions listed in the guidance below should follow the guidance on shielding and protecting for the extremely vulnerable. Which means staying at home at all times and avoiding any face-to-face contact for a period of at least 12 weeks
Statement on considerations for critical care for people with HIV during COVID-19
Please refer to the Critical Care Statement considerations for critical care for people with HIV during COVID-19 provided by BHIVA (31st March 2020)
Management of pregnant women living with HIV, and infant testing
Please refer to the statement 'Management of pregnant women living with HIV, and infant testing during COVID-19' provided by BHIVA (25th March)
Further information and resources:
Joint statement on risk of Coronavirus for people living with HIV BHIVA/EACS (1st April 2020)
- COVID-19 drug interactions website has been developed for the experimental drugs being trialled to treat COVID-19 in different parts of the world, supported by BHIVA and EASC.
- HIV Gov - Coronavirus (COVID-19) and People with HIV
- AIDS INFO Guidelines- for the Use of Antiretroviral Agents in Pediatric HIV Infection
- AIDS INFO Interim guidance for COVID-19 and persons with HIV (20th March)
- For further information on COVID-19 which explains what it is and how to protect yourself, as well as what we know about COVID-19 and HIV we suggest the THT COVID-19 Blog.